PROFIBRIX

profibrix-logo

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004

#People #Financial #Website #More

PROFIBRIX

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2004-01-01

Address:
Leiden, Zuid-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.profibrix.com

Total Employee:
11+

Status:
Closed

Contact:
31 88 730 8301

Email Addresses:
[email protected]

Total Funding:
33 M USD

Technology used in webpage:
GStatic Google Static Content Microsoft Microsoft Azure Microsoft Azure US East Region


Founder


jaap-koopman_image

Jaap Koopman

Investors List

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series B - ProFibrix

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - ProFibrix

index-ventures_image

Index Ventures

Index Ventures investment in Series B - ProFibrix

inkef-capital_image

Inkef

Inkef investment in Series B - ProFibrix

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series B - ProFibrix

index-ventures_image

Index Ventures

Index Ventures investment in Series A - ProFibrix

Official Site Inspections

http://www.profibrix.com

  • Host name: 191.236.54.126
  • IP address: 191.236.54.126
  • Location: Washington United States
  • Latitude: 38.7095
  • Longitude: -78.1539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 22747

Loading ...

More informations about "ProFibrix"

ProFibrix - Crunchbase Company Profile & Funding

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical โ€ฆSee details»

ProFibrix - Gilde Healthcare

Gilde acted as lead investor in its largest financing round. The company has since strengthened the organization, advanced its product pipeline, and clinically validated Fibrocapsโ„ข. The โ€ฆSee details»

ProFibrix Company Profile 2024: Valuation, Investors ... - PitchBook

ProFibrix General Information Description. Developer of products that help to stem post surgery bleeding. The company provides Fibrocaps, which is based on a mixture of two essential โ€ฆSee details»

ProFibrix BV - Company Profile and News - Bloomberg Markets

Company profile page for ProFibrix BV including stock price, company news, executives, board members, and contact informationSee details»

ProFibrix - Funding, Financials, Valuation & Investors - Crunchbase

ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.See details»

ProFibrix - Company Profile - Tracxn

ProFibrix - Powdered fibrin sealant for surgical bleeding. Acquired by The Medicines Company. Raised a total funding of $33M over 4 rounds from 5 investors. ProFibrix has 273 competitors.See details»

ProFibrix - VentureRadar

"ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets.See details»

ProFibrix - Tech Stack, Apps, Patents & Trademarks - Crunchbase

ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.See details»

ProFibrix B.V. - life-sciences-europe.com

Life Sciences Business Intelligence Web Portal for European countriesSee details»

The Medicines Company Signs Agreement to Acquire ProFibrix

Jun 4, 2013 Leiden, the Netherlands, Parsippany, NJ and Seattle, WA โ€“ The Medicines Company (NASDAQ: MDCO) and ProFibrix B.V. today announced an agreement for The โ€ฆSee details»

ProFibrix, Inc. - Company Profile & Staff Directory - ContactOut

Founded in 2004, ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets. Human fibrinogen โ€ฆSee details»

ProFibrix BV:Company Profile & Technical Research,Competitor โ€ฆ

ProFibrix BV is a company that provides Fibrinogen, Medicine, Hemostasis and more. ProFibrix BV is headquartered in Netherlands Zuid-Holland. ProFibrix BV was founded in 2004.See details»

ProFibrix (Group) - life-sciences-europe.com

Upcoming Events. ADLM 2024 Annual Meeting & Clinical Lab Expo Chicago (formerly AACC 2024) BIO-Europe 2024 Stockholm; BioFuture 2024 New York; HLTH Europe 2025 AmsterdamSee details»

ProFibrix | VentureRadar

Website: http://www.profibrix.com. ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and ...See details»

ProFibrix Company Profile - Life Science Intelligence

Human fibrinogen-based tissue sealant. Start Trial Get Full Profile. Thereโ€™s no risk. Start your trial today to see profiles of ProFibrix plus 5617 other startups.. Start Free 7 Day Trial NowSee details»

ProFibrix - Products, Competitors, Financials, Employees, โ€ฆ

VarmX appoints Dr. Jan Öhrström as CEO, and Dr. Alex Gold to Supervisory Board. Jun 15, 2021. VarmX appoints Dr. Jan Öhrström as CEO, and Dr. Alex Gold to Supervisory Board โ€ฆSee details»

ProFibrix โ€“ fibrinogen technology - Biotech 365

ProFibrix is a biotech company specialized in fibrinogen technology to develop innovative products for the hemostasis and regenerative medicine markets.See details»

ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing

Aug 24, 2009 ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing LEIDEN, The Netherlands and SEATTLE, August 24 -- ProFibrix B.V., a leader in the development of โ€ฆSee details»

Medicines Co. wraps $240M deal to buy ProFibrix following PhIII โ€ฆ

Aug 5, 2013 The Medicines Company has swooped in to buy out the Dutch biotech ProFibrix, chipping in $90 million in cash on top of a $10 million option anted up in June as Phase III data โ€ฆSee details»

Org Chart Creator: Free Organizational Chart Maker

Customizable Bricks Free Org Chart Creator. Create your org chart in seconds. Say goodbye to manual chart creation. Just copy-paste or import names, titles, managers, and even images โ€” โ€ฆSee details»

linkstock.net © 2022. All rights reserved